Hellstern medical GmbH

Robot-assisted surgery (RAS) is swiftly revolutionizing surgical procedures, offering an unparalleled economic opportunity alongside remarkable advancements in precision outcomes. 

Leading this transformative wave is the ExoRobot noac – an extraordinary sensor-controlled man-machine-synthesis that completely redefines surgical workplaces.

Unlike any other, the ExoRobot noac represents a trailblazing leap forward in surgical robotics, establishing unprecedented benchmarks. With its unmatched, patented innovation, it's positioned to become the universal standard in operating rooms worldwide. Our cutting-edge system ensures unparalleled surgical precision, independent of the surgeon’s daily physical and mental condition.

Furthermore, the ExoRobot noac serves as an incredibly versatile platform for seamless integration of additional functionalities such as cobots for instrument manipulation, surgical device control, and even AI assistance. This comprehensive approach not only elevates surgical capabilities but also maximizes efficiency and enhances patient outcomes to unprecedented levels.

Invest in the ExoRobot noac to capitalize on the thriving markets of exoskeleton and robotics, primed for explosive growth. With lucrative opportunities abound, especially in the dynamic landscapes of the USA, seizing this chance to invest in the ExoRobot noac is a strategic move. Analysts project the global market for robot-assisted surgery systems to experience an impressive growth rate surpassing 11%. Simultaneously, the exoskeleton market is expected to witness substantial annual growth of 45%. 

This groundbreaking technology presents a total market opportunity exceeding $49 billion. 

Join us in this exciting journey by making a Series A investment of up to $ 7 million. 

Let's schedule a video call to explore further. Don't let this remarkable opportunity slip away – invest in Hellstern medical and become part of shaping the future of surgery and robotics.